Tagged with Institute for Glycomics

New research has successfully switched off a key pathway of nerve fibre breakdown in debilitating neurodegenerative disorders

The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.

Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.

A Griffith study has found childhood COVID vaccination leads to high reductions in child disease and mortality, but is more beneficial to adults, particularly the unvaccinated.

Institute for Glycomics researchers receive funding boost in their fight against cancer with $2.6 million awarded by the Australian Cancer Research Foundation.

Griffith University researchers have secured more than $2.6M in NHMRC Ideas Grants.

Broad-spectrum malaria vaccine can be freeze-dried making it suitable for deployment into malaria-endemic countries.